What was the market valuation of the induced pluripotent-stem-cells market in 2024?

The market valuation was $119.75 Million in 2024. Read More

What is the projected market valuation for the induced pluripotent-stem-cells market by 2035?

The projected valuation for 2035 is $348.98 Million. Read More

What is the expected CAGR for the induced pluripotent-stem-cells market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period is 10.21%. Read More

What application segment had the highest valuation in 2024?

The Regenerative Medicine application segment had a valuation of $90.0 Million. Read More

What is the projected valuation for the Gene Therapy application segment by 2035?

The Gene Therapy application segment is projected to reach $83.98 Million by 2035. Read More

Which cell type segment is expected to show the highest growth in the coming years?

The Mesenchymal Stem Cells segment, valued at $151.98 Million by 2035, is expected to show significant growth. Read More

What is the valuation range for the Neurons cell type segment in 2024?

The Neurons cell type segment had a valuation range of $25.0 Million to $70.0 Million in 2024. Read More

Which source of induction is projected to have the highest valuation by 2035?

Viral Vectors are projected to reach $88.98 Million by 2035. Read More

What is the expected valuation for Biotechnology Companies as end users by 2035?

Biotechnology Companies are expected to have a valuation of $100.0 Million by 2035. Read More

Italy Induced Pluripotent Stem Cells Market

Q: Which companies are considered key players in the induced pluripotent-stem-cells market?

Key players include Fujifilm Cellular Dynamics, Astellas Pharma Inc., Takara Bio Inc., and others. Read More

ID: MRFR/LS/50683-HCR

200 Pages

Nidhi Mandole

Last Updated: February 06, 2026

Italy Induced Pluripotent Stem Cells Market Research Report: Size, Share, Trend Analysis By Applications (Regenerative Medicine, Drug Discovery, Disease Modeling, Toxicology Testing, Gene Therapy), By Cell Type (Cardiomyocytes, Neurons, Hepatocytes, Pancreatic Cells, Mesenchymal Stem Cells), By Source of Induction (Transcription Factors, Small Molecules, MicroRNA, Electroporation, Viral Vectors) andBy End Users (Pharmaceutical Companies, Research Institutes, Biotechnology Companies, Academic Institutions) - Growth Outlook & Industry Forecast 2025 To 2035

Italy Induced Pluripotent Stem Cells Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)10.21%

2024 Market Size$ 119.75 Million

2025 Market Size$ 131.98 Million

2035 Market Size$ 348.98 Million

Key Players

Fujifilm Cellular Dynamics

Astellas Pharma Inc.

Takara Bio Inc.

ReproCELL Inc.

Lonza Group AG

Thermo Fisher Scientific Inc.

Trends

Research Collaborations
Regulatory Support
Clinical Integration

Opportunities

Regulatory Framework Enhancements
Advancements in Stem Cell Research
Rising Investment in Biotechnology

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Application (USD Million)
  1. 4.1.1 Regenerative Medicine
  2. 4.1.2 Drug Discovery
  3. 4.1.3 Disease Modeling
  4. 4.1.4 Toxicology Testing
  5. 4.1.5 Gene Therapy
2. 4.2 Medical Device, BY Cell Type (USD Million)
  1. 4.2.1 Cardiomyocytes
  2. 4.2.2 Neurons
  3. 4.2.3 Hepatocytes
  4. 4.2.4 Pancreatic Cells
  5. 4.2.5 Mesenchymal Stem Cells
3. 4.3 Medical Device, BY Source of Induction (USD Million)
  1. 4.3.1 Transcription Factors
  2. 4.3.2 Small Molecules
  3. 4.3.3 MicroRNA
  4. 4.3.4 Electroporation
  5. 4.3.5 Viral Vectors
4. 4.4 Medical Device, BY End User (USD Million)
  1. 4.4.1 Pharmaceutical Companies
  2. 4.4.2 Research Institutes
  3. 4.4.3 Biotechnology Companies
  4. 4.4.4 Academic Institutions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Fujifilm Cellular Dynamics (JP)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Astellas Pharma Inc. (JP)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Takara Bio Inc. (JP)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 ReproCELL Inc. (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Lonza Group AG (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Thermo Fisher Scientific Inc. (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 MilliporeSigma (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Cellectis (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 ITALY MARKET ANALYSIS BY APPLICATION
3. 6.3 ITALY MARKET ANALYSIS BY CELL TYPE
4. 6.4 ITALY MARKET ANALYSIS BY SOURCE OF INDUCTION
5. 6.5 ITALY MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY CELL TYPE, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY CELL TYPE, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY SOURCE OF INDUCTION, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY SOURCE OF INDUCTION, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY CELL TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY SOURCE OF INDUCTION, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Italy Medical Device Market Segmentation

Medical Device By Application (USD Million, 2025-2035)

Regenerative Medicine
Drug Discovery
Disease Modeling
Toxicology Testing
Gene Therapy

Medical Device By Cell Type (USD Million, 2025-2035)

Cardiomyocytes
Neurons
Hepatocytes
Pancreatic Cells
Mesenchymal Stem Cells

Medical Device By Source of Induction (USD Million, 2025-2035)

Transcription Factors
Small Molecules
MicroRNA
Electroporation
Viral Vectors

Medical Device By End User (USD Million, 2025-2035)

Pharmaceutical Companies
Research Institutes
Biotechnology Companies
Academic Institutions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”